Showing results (21-30 of 158) with videos related to
Sort By:
Pageof 16
Cancer Biomarkers : Section a of Disease Markers|December 1, 2007
African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic reviewDominik D Alexander, John Waterbor, Timothy Hughes, et al.The Journal of Surgical Research|January 26, 2015
Nanomagnetic levitation three-dimensional cultures of breast and colorectal cancersHarvey L Bumpers, Dasharatham G Janagama, Upender Manne, et al.Cancer Biomarkers : Section a of Disease Markers|November 25, 2011
Development and progression of colorectal neoplasiaUpender Manne, Chandrakumar Shanmugam, Venkat R Katkoori, et al.BMC Cancer|August 20, 2014
Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugsTemesgen Samuel, Khalda Fadlalla, Dominique N Gales, et al.Current Oncology (Toronto, Ont.)|March 27, 2024
Unlocking the Potential of Therapy-Induced Cytokine Responses: Illuminating New Pathways in Cancer Precision MedicineDilip R Gunturu, Mohammed Hassan, Deepa Bedi, et al.Cancer|June 29, 2004
Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinomaDominik Alexander, Chakrapani Chatla, Ellen Funkhouser, et al.Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 8, 2021
GLI1-targeting drugs induce replication stress and homologous recombination deficiency and synergize with PARP-targeted therapies in triple negative breast cancer cellsChinnadurai Mani, Kaushlendra Tripathi, Tasmin R Omy, et al.Translational Oncology|January 6, 2022
The interplay of pineal hormones and socioeconomic status leading to colorectal cancer disparityTalaijha Haynes, Gabriela Oprea-Ilies, Upender Manne, et al.Oncotarget|August 31, 2015
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancersVenkat R Katkoori, Marc D Basson, Vincent C Bond, et al.Cancer|September 11, 2019
Inclusiveness and ethical considerations for observational, translational, and clinical cancer health disparity researchMichael Behring, Kevin Hale, Bunyamin Ozaydin, et al.Pageof 16